CLINICAL_TRIALS
trial_result
· 2022-04-08
Clinical Trial Update: BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT [Phase 3]
Summary
Phase 3 trial comparing BuCY versus TBICY conditioning regimens for standard-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan | Phase 3 | Status: COMPLETED